Yu W - Search Results

1

Nanocytology as a potential biomarker for cancer.

Yu W, Sharma S, Gimzewski JK, Rao J. Yu W, et al. Biomark Med. 2017 Mar;11(3):213-216. doi: 10.2217/bmm-2017-0019. Epub 2017 Feb 16. Biomark Med. 2017. PMID: 28240098 Free article. No abstract available.

2

Single Cell Mechanotype and Associated Molecular Changes in Urothelial Cell Transformation and Progression.

Yu W, Lu QY, Sharma S, Ly C, Di Carlo D, Rowat AC, LeClaire M, Kim D, Chow C, Gimzewski JK, Rao J. Yu W, et al. Front Cell Dev Biol. 2020 Nov 19;8:601376. doi: 10.3389/fcell.2020.601376. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33330495 Free PMC article.

3

A Preliminary Study of Deep-Learning Algorithm for Analyzing Multiplex Immunofluorescence Biomarkers in Body Fluid Cytology Specimens.

Yu W, Rao E, Chin CD, Aguilar-Jakthong JS, Li Y, Chow C, Wang SYG, Rao J. Yu W, et al. Acta Cytol. 2021;65(4):348-353. doi: 10.1159/000515976. Epub 2021 Jun 2. Acta Cytol. 2021. PMID: 34077933 Free article.

4

Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma.

Yu WB, Rao JY. Yu WB, et al. Chronic Dis Transl Med. 2019 Sep 26;5(3):170-177. doi: 10.1016/j.cdtm.2019.08.003. eCollection 2019 Sep. Chronic Dis Transl Med. 2019. PMID: 31891128 Free PMC article.

5

Management of centrally located hepatocellular carcinoma: Update 2016.

Yu WB, Rao A, Vu V, Xu L, Rao JY, Wu JX. Yu WB, et al. World J Hepatol. 2017 May 8;9(13):627-634. doi: 10.4254/wjh.v9.i13.627. World J Hepatol. 2017. PMID: 28539990 Free PMC article. Review.

6

Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter.

Yu W, Qin X, Jin Y, Li Y, Santiskulvong C, Vu V, Zeng G, Zhang Z, Chow M, Rao J. Yu W, et al. Oncotarget. 2017 Jan 31;8(5):7977-7988. doi: 10.18632/oncotarget.13939. Oncotarget. 2017. PMID: 28002788 Free PMC article.

7

Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways.

Wang L, Feng L, Rong W, Liu M, Wu F, Yu W, An S, Zhou X, Wu J. Wang L, et al. Among authors: yu w. J Gastrointest Surg. 2019 Sep;23(9):1767-1777. doi: 10.1007/s11605-018-3960-1. Epub 2018 Dec 12. J Gastrointest Surg. 2019. PMID: 30542823 Free PMC article.

8

Adjuvant radiotherapy in central hepatocellular carcinoma after narrow-margin hepatectomy: A 10-year real-world evidence.

Rong W, Yu W, Wang L, Wu F, Zhang K, Chen B, Miao C, Liu L, An S, Tao C, Wang W, Wu J. Rong W, et al. Among authors: yu w. Chin J Cancer Res. 2020 Oct 31;32(5):645-653. doi: 10.21147/j.issn.1000-9604.2020.05.09. Chin J Cancer Res. 2020. PMID: 33223759 Free PMC article.

9

The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<1 cm) hepatectomy: a prospective, phase 2 study.

Wang L, Liu Y, Rong W, Wu F, Yu W, Liu K, Lin S, Zheng Y, Zhang K, Siqin T, Tao C, Liu M, Chen B, Feng Q, Wu J. Wang L, et al. Among authors: yu w. Hepatobiliary Surg Nutr. 2022 Aug;11(4):515-529. doi: 10.21037/hbsn-21-223. Hepatobiliary Surg Nutr. 2022. PMID: 36016755 Free PMC article.

10

Targeting tumor suppressor p53 for organ fibrosis therapy.

Bao YN, Yang Q, Shen XL, Yu WK, Zhou L, Zhu QR, Shan QY, Wang ZC, Cao G. Bao YN, et al. Among authors: yu wk. Cell Death Dis. 2024 May 14;15(5):336. doi: 10.1038/s41419-024-06702-w. Cell Death Dis. 2024. PMID: 38744865 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,451 results

Search Page